RESULTS	After a median follow-up of 100 months ( IQR 72-132 ) , median PFS with pomalidomide plus low-dose dexamethasone was 40 months ( 95 % CI 36-47 ) versus 19 months ( 19-22 ) with high-dose dexamethasone ( hazard ratio 048 [ 95 % CI 039-060 ] ; p < 00001 ) .\